Various studies have demonstrated that TGF-β signaling can play contradictory roles in tumor progression: TGF-β inhibits growth in normal and premalignant epithelial cells; whereas, tumor cells become insensitive to the growth-inhibitory effects of TGF-β signaling by accumulating multiple genetic and epigenetic alterations. Here, TGFB1 is linked to neoplasm.